Hepatic Artery Infusion With Oxaliplatin
Colorectal Cancer, Metastasis, Liver Cancer
About this trial
This is an interventional treatment trial for Colorectal Cancer focused on measuring hepatic artery infusion, colorectal cancer, liver metastasis, oxaliplatin, 5 fluorouracil
Eligibility Criteria
Inclusion Criteria: Signed consent Age greater than 17 years Stage IV colorectal cancer Metastasis limited to the liver considered unresectable for cure by standard methods Completely resected primary tumor Life expectancy greater than 3 years excluding cancer Eastern Cooperative Oncology Group (ECOG) status 0, 1, 2 Absolute granulocyte count greater than 1500 Platelet count greater than 100,000 Adequate hepatic function Adequate renal function Exclusion Criteria: Concomitant anticancer therapy other than this protocol Gastroduodenal ulcer Pregnancy or lactation Last treatment for colon cancer less than 4 weeks from this protocol
Sites / Locations
- Medical College of Wisconsin/ Froedtert Hospital